Hexagon Capital Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-449
| Closed | -$12.7K | – | 1088 |
|
|
2025
Q1 | $12.7K | Sell |
449
-6
| -1% | -$170 | ﹤0.01% | 895 |
|
|
2024
Q4 | $18.9K | Buy |
455
+125
| +38% | +$5.2K | ﹤0.01% | 803 |
|
|
2024
Q3 | $22.1K | Buy |
330
+20
| +6% | +$1.34K | ﹤0.01% | 682 |
|
|
2024
Q2 | $36.7K | Buy |
310
+1
| +0.3% | +$118 | 0.01% | 505 |
|
|
2024
Q1 | $33K | Sell |
309
-301
| -49% | -$32.1K | 0.01% | 529 |
|
|
2023
Q4 | $60.6K | Buy |
610
+394
| +182% | +$39.1K | 0.01% | 366 |
|
|
2023
Q3 | $22.3K | Sell |
216
-54
| -20% | -$5.59K | 0.01% | 528 |
|
|
2023
Q2 | $32.8K | Sell |
270
-16
| -6% | -$1.95K | 0.01% | 450 |
|
|
2023
Q1 | $44K | Sell |
286
-8
| -3% | -$1.23K | 0.01% | 381 |
|
|
2022
Q4 | $52.9K | Sell |
294
-29
| -9% | -$5.22K | 0.02% | 345 |
|
|
2022
Q3 | $38K | Buy |
323
+78
| +32% | +$9.18K | 0.01% | 446 |
|
|
2022
Q2 | $35K | Buy |
245
+36
| +17% | +$5.14K | 0.01% | 429 |
|
|
2022
Q1 | $36K | Buy |
209
+200
| +2,222% | +$34.5K | 0.01% | 415 |
|
|
2021
Q4 | $2K | Hold |
9
| – | – | ﹤0.01% | 767 |
|
|
2021
Q3 | $4K | Buy |
+9
| New | +$4K | ﹤0.01% | 701 |
|